Form 4: Haemonetics Corp Executive Miller Reports Stock Transactions

Laurie A. Miller, SVP of Human Resources at Haemonetics Corp, reports acquisition of shares from performance share units and disposition of shares for tax obligations.

Summary

• Laurie A. Miller, SVP of Human Resources at Haemonetics Corp, filed a Form 4 detailing changes in beneficial ownership.
• On May 28, 2024, Miller acquired 2,650 shares of common stock from a performance share unit (PSU) award granted on May 18, 2021.
• The PSU award was based on Haemonetics' total shareholder return relative to the S&P MidCap 400 Index from May 18, 2021, to May 17, 2024.
• The Compensation Committee of the Board of Directors certified the performance on May 26, 2024.
• Also on May 28, 2024, Miller disposed of 778 shares of common stock at $95.73 per share to cover tax obligations related to the vesting of the PSUs.
• Following these transactions, Miller beneficially owns 18,045 shares of Haemonetics Corp common stock, including unvested restricted stock units (RSUs).

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.

Positives

• The vesting of performance share units indicates that Haemonetics met certain performance criteria related to shareholder return relative to the S&P MidCap 400 Index.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Executive compensation packages often include performance-based equity awards like PSUs to align management's interests with those of shareholders.
• The vesting of PSUs based on relative TSR performance against an index like the S&P MidCap 400 is a common practice among publicly traded companies.
• Companies like Medtronic and Baxter International also use similar performance metrics in their executive compensation plans.

Stakeholder Impact

• The vesting of PSUs could be viewed positively by shareholders as it indicates the company met certain performance targets.
• The sale of shares to cover tax obligations has a negligible impact on stakeholders.

Key Dates